World Orphan Drug Congress Europe
23 – 25 October, 2024 // Barcelona, Spain
Join Worldwide Clinical Trials at World Orphan Drug Congress Europe.
0
days leftAbout event
WODC is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. If you are attending, stop by booth #30 and say hello to our team.
Drew Matheson, Franchise Area Lead, Rare Disease, will be presenting Bridging the Gap: Clinical Trials as a Standard of Care in Rare Diseases on 23 October at 2:10 P.M CEST.
Derek Ansel, Vice President, Therapeutic Strategy Lead, Rare Disease, will be in a Working Group, that is scheduled for 23 October at 11:30 A.M. CEST titled, Shifting Strands: Operational Challenges and Ethical Dilemmas of Genetic Testing.
Date
Wednesday to Friday
23 – 25 October, 2024
Venue
Fira de Barcelona Montjuic
Av. de la Reina Maria Cristina, s/n, Sants-Montjuïc, 08004 Barcelona, Spain
Drew Matheson
Franchise Area Lead, Rare Disease
Drew Matheson is a Franchise Area Lead within the Rare Disease team at Worldwide and has over 25 years of experience in clinical trials and is passionate about bringing new therapies to patients.
